Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
This launch is part of the company's strategy to expand its nutraceutical portfolio
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
Subscribe To Our Newsletter & Stay Updated